UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

Journal of clinical oncology, 2018-07, Vol.36 (20), p.2024-2034

2018

Volltextzugriff (PDF)

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy

Cancer medicine (Malden, MA), 2020-11, Vol.9 (22), p.8386-8396

2020

Volltextzugriff (PDF)

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification

Journal of hematology and oncology, 2016-09, Vol.9 (1), p.78-78, Article 78

2016

Volltextzugriff (PDF)

Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis

Hematology (Luxembourg), 2018-07, Vol.23 (6), p.324-329

2018

Volltextzugriff (PDF)

Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia

Annals of hematology, 2005-12, Vol.84 Suppl 1 (S1), p.39-46

2005

Volltextzugriff (PDF)

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

The Lancet (British edition), 2019-01, Vol.393 (10167), p.156-167

2019

Volltextzugriff (PDF)

Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma

Epigenetics, 2011-08, Vol.6 (8), p.1047-1052

2011

Volltextzugriff (PDF)

Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation

Clinical epigenetics, 2012-08, Vol.4 (1), p.12-12, Article 12

2012

Volltextzugriff (PDF)

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

Journal of cancer research and clinical oncology, 2009-10, Vol.135 (10), p.1429-1435

2009

Volltextzugriff (PDF)

Comparison of flow‐FISH and MM–qPCR telomere length assessment techniques for the screening of telomeropathies

Annals of the New York Academy of Sciences, 2020-04, Vol.1466 (1), p.93-103

2020

Volltextzugriff (PDF)

A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma

Drug delivery and translational research, 2023-04, Vol.13 (4), p.915-923

2023

Volltextzugriff (PDF)

Androgen Derivatives Improve Blood Counts and Elongate Telomere Length in Patients with Dyskeratosis Congenita

Blood, 2018-11, Vol.132 (Supplement 1), p.2585-2585

2018

Volltextzugriff (PDF)

Comparison of Fluorescence in Situ Hybridization and Flow Cytometry (Flow-FISH) with Monochrome Multiplex Quantitative Polymerase Chain Reaction (MM-qPCR) for Telomere Length Screening in Adult Patients with Suspected Cryptic Dyskeratosis Congenita (DKC)

Blood, 2018-11, Vol.132 (Supplement 1), p.3861-3861

2018

Volltextzugriff (PDF)

Accelerated telomere shortening in peripheral blood lymphocytes after occupational polychlorinated biphenyls exposure

Archives of toxicology, 2017-01, Vol.91 (1), p.289-300

2017

Volltextzugriff (PDF)

Surgical Resection of Urological Tumor Metastases Following Medical Treatment

Deutsches Ärzteblatt international, 2012-09

2012

Volltextzugriff (PDF)

Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility

European journal of haematology, 2021-09, Vol.107 (3), p.324-332

2021

Volltextzugriff (PDF)

Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia

Annals of hematology, 2017-09, Vol.96 (9), p.1457-1461

2017

Volltextzugriff (PDF)

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Annals of hematology, 2019-04, Vol.98 (4), p.897-907

2019

Volltextzugriff (PDF)

Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial

Hematological oncology, 2020-08, Vol.38 (3), p.244-256

2020

Volltextzugriff (PDF)

A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia

European journal of haematology, 2016-07, Vol.97 (1), p.17-24

2016

Volltextzugriff (PDF)

Prevention of psychosocial morbidity and improvement of coping strategies: Effects of a cancer patient and caregiver centred information series

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e20566-e20566

2014

Volltextzugriff (PDF)

Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation

Annals of hematology, 2012-07, Vol.91 (7), p.1115-1120

2012

Volltextzugriff (PDF)

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

Blood, 2015-12, Vol.126 (23), p.3880-3880

2015

Volltextzugriff (PDF)

Surgical resection of urological tumor metastases following medical treatment

Deutsches Ärzteblatt international, 2012-09, Vol.109 (39), p.631-637

2012

Volltextzugriff (PDF)

A Phase 1, First-in-Human Study of AMG 176, a Selective MCL-1 Inhibitor, in Patients With Relapsed or Refractory Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e53-e54

2019

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(63)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy

A three-gene expression-based risk score can refine the European LeukemiaNet AML classification

Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis

Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma

Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

Comparison of flow‐FISH and MM–qPCR telomere length assessment techniques for the screening of telomeropathies

A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma

Androgen Derivatives Improve Blood Counts and Elongate Telomere Length in Patients with Dyskeratosis Congenita

Comparison of Fluorescence in Situ Hybridization and Flow Cytometry (Flow-FISH) with Monochrome Multiplex Quantitative Polymerase Chain Reaction (MM-qPCR) for Telomere Length Screening in Adult Patients with Suspected Cryptic Dyskeratosis Congenita (DKC)

Accelerated telomere shortening in peripheral blood lymphocytes after occupational polychlorinated biphenyls exposure

Surgical Resection of Urological Tumor Metastases Following Medical Treatment

Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility

Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial

A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia

Prevention of psychosocial morbidity and improvement of coping strategies: Effects of a cancer patient and caregiver centred information series

Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

Surgical resection of urological tumor metastases following medical treatment

A Phase 1, First-in-Human Study of AMG 176, a Selective MCL-1 Inhibitor, in Patients With Relapsed or Refractory Multiple Myeloma

Suchergebnisse filtern